• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Norepinephrine as a First-Line Inopressor in Cardiogenic Shock: Oversimplification or Best Practice?

作者信息

van Diepen Sean

机构信息

Department of Critical Care and Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Canadian VIGOUR Center, University of Alberta, Edmonton, Alberta, Canada.

出版信息

J Am Coll Cardiol. 2018 Jul 10;72(2):183-186. doi: 10.1016/j.jacc.2018.04.052.

DOI:10.1016/j.jacc.2018.04.052
PMID:29976292
Abstract
摘要

相似文献

1
Norepinephrine as a First-Line Inopressor in Cardiogenic Shock: Oversimplification or Best Practice?去甲肾上腺素作为心源性休克的一线血管活性药物：过度简化还是最佳实践？
J Am Coll Cardiol. 2018 Jul 10;72(2):183-186. doi: 10.1016/j.jacc.2018.04.052.
2
Norepinephrine Versus Epinephrine in Cardiogenic Shock After Acute Myocardial Infarction: Do We Have an Answer?急性心肌梗死后心源性休克中去甲肾上腺素与肾上腺素的比较：我们有答案了吗？
J Am Coll Cardiol. 2018 Nov 6;72(19):2412. doi: 10.1016/j.jacc.2018.07.100.
3
Reply: Norepinephrine Versus Epinephrine in Cardiogenic Shock After Acute Myocardial Infarction: Do We Have an Answer?回复：急性心肌梗死后心源性休克中去甲肾上腺素与肾上腺素的比较：我们有答案了吗？
J Am Coll Cardiol. 2018 Nov 6;72(19):2413. doi: 10.1016/j.jacc.2018.09.008.
4
Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock.伴有和不伴有心源性休克的心肌梗死患者的血浆肾上腺素、去甲肾上腺素浓度及多巴胺-β-羟化酶活性
Br Heart J. 1979 Aug;42(2):214-20. doi: 10.1136/hrt.42.2.214.
5
Pharmacologic support in cardiogenic shock.心源性休克的药物支持
Adv Shock Res. 1983;10:35-49.
6
Use of catecholamines in acute myocardial infarction.儿茶酚胺在急性心肌梗死中的应用。
Herz. 1979 Oct;4(5):385-96.
7
Treatment of cardiogenic shock by prolonged administration of norepinephrine.通过长期给予去甲肾上腺素治疗心源性休克。
Can Med Assoc J. 1953 Jun;68(6):596-8.
8
Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.左西孟旦作为ST段抬高型心肌梗死后严重心源性休克的挽救治疗。
Acute Card Care. 2008;10(3):185-90. doi: 10.1080/17482940801935774.
9
[Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?].[儿茶酚胺疗法在心源性休克中的作用：有益、无用还是危险？]
Dtsch Med Wochenschr. 2004 Sep 10;129(37):1925-30. doi: 10.1055/s-2004-831364.
10
PROLONGED CARDIOGENIC SHOCK. REPORT OF A CASE IN WHICH PREVIOUS PROLONGED THERAPY WITH A RESERPINE-LIKE DRUG MAY HAVE PLAYED A ROLE.持续性心源性休克。一例报告，其中既往使用类似利血平药物的长期治疗可能起到了一定作用。
Am J Med. 1963 Sep;35:396-403. doi: 10.1016/0002-9343(63)90181-5.

引用本文的文献

1
Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?血管加压素及其类似物在感染性休克患者中的应用：圣杯还是未兑现的承诺？
Crit Care. 2025 Jul 29;29(1):333. doi: 10.1186/s13054-025-05540-2.
2
The Management of Cardiogenic Shock From Diagnosis to Devices: A Narrative Review.从诊断到器械治疗的心源性休克管理：一篇叙述性综述
CHEST Crit Care. 2024 Jun;2(2). doi: 10.1016/j.chstcc.2024.100071. Epub 2024 Apr 16.
3
Revisiting nitrates use in pre-shock state of contemporary cardiogenic shock classification.
重新审视当代心源性休克分类中休克前期状态下硝酸盐的使用。
Front Cardiovasc Med. 2024 Jan 4;10:1173168. doi: 10.3389/fcvm.2023.1173168. eCollection 2023.
4
Circulatory shock in adults in emergency department.成人急诊科的循环性休克
Turk J Emerg Med. 2023 Jan 9;23(3):139-148. doi: 10.4103/2452-2473.367400. eCollection 2023 Jul-Sep.
5
Alpha-Adrenergic Mechanisms in the Cardiovascular Hyperreactivity to Norepinephrine-Infusion in Essential Hypertension.原发性高血压患者对去甲肾上腺素输注引起心血管反应性增强与肾上腺素能机制有关。
Front Endocrinol (Lausanne). 2022 Jul 22;13:824616. doi: 10.3389/fendo.2022.824616. eCollection 2022.
6
Evolving Presentation of Cardiogenic Shock: A Review of the Medical Literature and Current Practices.心源性休克的演变表现：医学文献与当前实践综述
Cardiol Ther. 2022 Sep;11(3):369-384. doi: 10.1007/s40119-022-00274-6. Epub 2022 Aug 7.
7
Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality.去甲肾上腺素在心源休克患者中的应用与 30 天死亡率的增加相关。
ESC Heart Fail. 2022 Jun;9(3):1875-1883. doi: 10.1002/ehf2.13893. Epub 2022 Mar 14.
8
Vasoactive pharmacologic therapy in cardiogenic shock: a critical review.心源性休克中的血管活性药物治疗：一项批判性综述
J Drug Assess. 2021 Jul 20;10(1):68-85. doi: 10.1080/21556660.2021.1930548. eCollection 2021.
9
Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.乳酸血症与晚期心力衰竭患者血液动力学的不匹配。
Clin Cardiol. 2021 May;44(5):636-645. doi: 10.1002/clc.23584. Epub 2021 Mar 18.
10
Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience.在静脉-动脉体外膜肺氧合植入术中使用肾上腺素、正性肌力药或不使用正性肌力药：一项单中心经验。
Crit Care. 2019 Sep 18;23(1):320. doi: 10.1186/s13054-019-2605-4.